Ethyl orthoformate → 3-((3S,9aS)-8-(2-(2-(1H-tetrazol-1-yl)pyrimidin-5-yl)-2,2-difluoroacetyl)octahydropyrazino[2,1-c][1,4]oxazin-3-yl)-6-fluoro-2-methylbenzonitrile

HRID 1502179ノート

反応式

HRID 1502179 の反応式
FC(F)(F)C(O[Si](C)(C)C)=O.[NH2:12][C:13]1[N:18]=[CH:17][C:16]([C:19]([F:43])([F:42])[C:20]([N:22]2[CH2:31][CH2:30][N:29]3[C@H:24]([CH2:25][O:26][C@@H:27]([C:32]4[C:33]([CH3:41])=[C:34]([C:37]([F:40])=[CH:38][CH:39]=4)[C:35]#[N:36])[CH2:28]3)[CH2:23]2)=[O:21])=[CH:15][N:14]=1.[CH:44](OCC)(OCC)OCC.[N:54]([Si](C)(C)C)=[N+:55]=[N-:56]>C(OCC)(=O)C.CO>[N:12]1([C:13]2[N:14]=[CH:15][C:16]([C:19]([F:43])([F:42])[C:20]([N:22]3[CH2:31][CH2:30][N:29]4[C@H:24]([CH2:25][O:26][C@@H:27]([C:32]5[C:33]([CH3:41])=[C:34]([C:37]([F:40])=[CH:38][CH:39]=5)[C:35]#[N:36])[CH2:28]4)[CH2:23]3)=[O:21])=[CH:17][N:18]=2)[CH:44]=[N:54][N:55]=[N:56]1

参加物

7

反応物 4

HCID 31214Ethyl orthoformateHCID 67863Acetic acid, 2,2,2-trifluoro-, trimethylsilyl esterHCID 78378AzidotrimethylsilaneHCID 1176902733-((3S,9aS)-8-(2-(2-aminopyrimidin-5-yl)-2,2-difluoroacetyl)octahydropyrazino[2,1-c][1,4]oxazin-3-yl)-6-fluoro-2-methylbenzonitrile

生成物 1

HCID 716038553-((3S,9aS)-8-(2-(2-(1H-tetrazol-1-yl)pyrimidin-5-yl)-2,2-difluoroacetyl)octahydropyrazino[2,1-c][1,4]oxazin-3-yl)-6-fluoro-2-methylbenzonitrile

試薬・触媒・溶媒 2

HCID 887Methanol溶媒HCID 8857Ethyl Acetate溶媒

実験手順

Trimethylsilyl trifluoroacetate (23.8 μL, 0.137 mmol) was added to a suspension of 3-((3S,9aS)-8-(2-(2-aminopyrimidin-5-yl)-2,2-difluoroacetyl)octahydropyrazino[2,1-c][1,4]oxazin-3-yl)-6-fluoro-2-methylbenzonitrile (36.1 mg, 0.081 mmol) in ethyl acetate (735 μL). The mixture was stirred for 5 min at room temperature and triethyl orthoformate (23.67 μL, 0.142 mmol) was added. After stirring for 5 more min at room temperature, azidotrimethylsilane (16.91 μL, 0.129 mmol) was added. The mixture was stirred at room temperature overnight. The reaction mixture was diluted with methanol and purified on mass-directed preparative HPLC. Appropriate fractions were collected and solvent was removed under reduced pressure. The residue was converted to hydrochloric acid salt. LC/MS: [(M+1)]+=500.0; 1H NMR (500 MHz, DMSO-d6) δ 10.33 (s, 1H), 9.35 (s, 2H), 7.85-7.94 (m, 1H), 7.43-7.54 (m, 1H), 5.14-5.27 (m, 1H), 4.01-4.60 (m, 5H), 3.13-3.95 (m, 6H), 2.53 (s, 3H).

後処理

  1. stirringAfter stirring for 5 more min at room temperature
  2. stirringThe mixture was stirred at room temperature overnight
  3. custompurified on mass-directed preparative HPLC
  4. customAppropriate fractions were collected
  5. customsolvent was removed under reduced pressure

出典と根拠

ORDレコード
ord-437fe99024d14f0bb976f112a9cc4662
出典データセット
uspto-grants-2015_12
特許番号
US09206199B2

反応ノート

読み込み中…